ALDOA, the gene encoding the glycolysis enzyme that converts fructose-1,6-bisphosphate to glyceraldehyde-3-phosphate, has been shown to correlate with poor prognosis in pancreatic cancer patients [38]. This evidence concerns the gene ALDOA and pancreatic neoplasm.